Total raised
$176.2M
Last: Debt Financing 2024-08
Stage
Public
Founded
2014
Headcount
14
HQ
Haifa
Sector
Health Tech & Life Sciences
About
NeuroRX is a specialized CNS biopharma company, resolutely focused on meeting very high unmet medical needs for those with severe bipolar depression with suicidality and post-traumatic stress disorder (PTSD).
The company growing pipeline is powered by its proprietary, dual-targeted mechanism of action, which safely modulates the NMDA and 5HT2A receptors. Its mission is to bring hope to people with life-threatening diseases through breakthrough science.
Funding history · 5 rounds · $176.2M total
2024-08
Debt Financing
$16.0M
2024-03
PIPE
$2.9M
2023-06
PIPE
$6.3M
2022-11
Debt Financing
$11.0M
2022-01
PIPE
$25.0M
Sectors & technology
Primary sector
Health Tech & Life Sciences
Sub-sectors
Health Tech & Life SciencesPharma & Medical BiotechnologyDrugs Discovery & Development
Technologies
BiologicalsMolecules
Target customers
Healthcare & Life SciencesHealthcarePatientsProviders
Business model
B2B
Highlights
1 PatentsVerified
Tags
mental-healthpsychiatrypharmaceuticalsschizophreniachronic-pain